<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04272632</url>
  </required_header>
  <id_info>
    <org_study_id>Yi Chen-2020-3</org_study_id>
    <nct_id>NCT04272632</nct_id>
  </id_info>
  <brief_title>Coload Optimization Guided by Inferior Vena Cava Collapsibility Index</brief_title>
  <official_title>Coload Optimization Guided by Inferior Vena Cava Collapsibility Index in Parturients With Prophylactic Norepinephrine Infusion Undergoing Cesarean Section: a Randomized, Dose-finding Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>General Hospital of Ningxia Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>General Hospital of Ningxia Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the optimal coload guided by inferior vena cava
      collapsibility index in parturients with prophylactic norepinephrine infusion undergoing
      cesarean section.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for
      cesarean section. The incidence of post-spinal anesthesia hypotension is as high as
      62.1-89.7% if prophylactic measures are not taken. Vasopressors has been highly recommended
      for routine prevention and/or treatment of post-spinal anesthesia hypotension. As a potential
      substitute drug for phenylephrine, norepinephrine has gradually been used in parturients
      undergoing cesarean section. There's some evidence that prophylactic infusion of
      norepinephrine could effectively reduce the incidence of post-spinal anesthesia hypotension
      in parturients undergoing cesarean section. However, our study (NCT03997500) had been shown
      that inferior vena cava collapsibility index (IVC-CI) markedly decreased in prophylactic
      norepinephrine infusion versus normal saline after spinal anesthesia and fetal delivery,
      suggesting that more prudent fluid management is required. The ideal dose of coload and
      coload is still unknown. Thus, the purpose of this study is to investigate the optimal coload
      guided by IVC-CI in parturients with prophylactic norepinephrine infusion undergoing cesarean
      section.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The minimum (IVC-min), maximum diameter (IVC-max) and collapsibility index (IVC-CI) of the inferior vena cava (IVC)</measure>
    <time_frame>Baseline (before preload)</time_frame>
    <description>IVC-CI = [(IVC-max-IVC-min) /IVC-max*100%]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The minimum (IVC-min), maximum diameter (IVC-max) and collapsibility index (IVC-CI) of the inferior vena cava (IVC)</measure>
    <time_frame>Before spinal anesthesia (after preload)</time_frame>
    <description>IVC-CI = [(IVC-max-IVC-min) /IVC-max*100%]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The minimum (IVC-min), maximum diameter (IVC-max) and collapsibility index (IVC-CI) of the inferior vena cava (IVC)</measure>
    <time_frame>5 min after spinal anesthesia</time_frame>
    <description>IVC-CI = [(IVC-max-IVC-min) /IVC-max*100%]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The minimum (IVC-min), maximum diameter (IVC-max) and collapsibility index (IVC-CI) of the inferior vena cava (IVC)</measure>
    <time_frame>5 min after fetal delivery</time_frame>
    <description>IVC-CI = [(IVC-max-IVC-min) /IVC-max*100%]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The minimum (IVC-min), maximum diameter (IVC-max) and collapsibility index (IVC-CI) of the inferior vena cava (IVC)</measure>
    <time_frame>Before leaving the operating room</time_frame>
    <description>IVC-CI = [(IVC-max-IVC-min) /IVC-max*100%]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of post-spinal anesthesia hypotension.</measure>
    <time_frame>1-15 minutes after spinal anesthesia</time_frame>
    <description>Systolic blood pressure (SBP) &lt; 80% of the baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of severe post-spinal anesthesia hypotension.</measure>
    <time_frame>1-15 minutes after spinal anesthesia</time_frame>
    <description>Systolic blood pressure (SBP) &lt; 60% of the baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of nausea and vomiting.</measure>
    <time_frame>1-15 minutes after spinal anesthesia</time_frame>
    <description>Presence of nausea and vomiting in patients after spinal anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of bradycardia</measure>
    <time_frame>1-15 minutes after spinal anesthesia</time_frame>
    <description>Heart rate &lt; 55 beats/min.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of hypertension</measure>
    <time_frame>1-15 minutes after spinal anesthesia</time_frame>
    <description>Systolic blood pressure (SBP) &gt;120% of the baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pH</measure>
    <time_frame>Immediately after delivery</time_frame>
    <description>From umbilical vein blood gases</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Partial pressure of oxygen</measure>
    <time_frame>Immediately after delivery</time_frame>
    <description>From umbilical vein blood gases</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Base excess</measure>
    <time_frame>Immediately after delivery</time_frame>
    <description>From umbilical vein blood gases</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>APGAR score</measure>
    <time_frame>1min after delivery</time_frame>
    <description>A= Appearance P=Pulse G=Grimace A=Attitude R=Respiration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>APGAR score</measure>
    <time_frame>5min after delivery</time_frame>
    <description>A= Appearance P=Pulse G=Grimace A=Attitude R=Respiration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall stability of systolic blood pressure control versus baseline</measure>
    <time_frame>1-15 minutes after spinal anesthesia.</time_frame>
    <description>Evaluated by performance error (PE).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall stability of heart rate control versus baseline</measure>
    <time_frame>1-15 minutes after spinal anesthesia.</time_frame>
    <description>Evaluated by performance error (PE).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Adverse Effect</condition>
  <arm_group>
    <arm_group_label>4 ml/kg group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given immediately after spinal anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8 ml/kg group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given immediately after spinal anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>12 ml/kg group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given immediately after spinal anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>4 ml/kg group</intervention_name>
    <description>4 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given immediately after spinal anesthesia.</description>
    <arm_group_label>4 ml/kg group</arm_group_label>
    <other_name>Crystalloid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>8 ml/kg group</intervention_name>
    <description>8 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given immediately after spinal anesthesia.</description>
    <arm_group_label>8 ml/kg group</arm_group_label>
    <other_name>Crystalloid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>12 ml/kg group</intervention_name>
    <description>12 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given immediately after spinal anesthesia.</description>
    <arm_group_label>12 ml/kg group</arm_group_label>
    <other_name>Crystalloid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-40 years

          -  Primipara or multipara

          -  Singleton pregnancy ≥37 weeks

          -  American Society of Anesthesiologists physical status classification I to II

          -  Scheduled for elective cesarean section under spinal anesthesia

        Exclusion Criteria:

          -  Body height &lt; 150 cm

          -  Body weight &gt; 100 kg or body mass index (BMI) ≥ 40 kg/m2

          -  Eclampsia or chronic hypertension or baseline blood pressure ≥ 160mmHg

          -  Hemoglobin &lt; 7g/dl

          -  Fetal distress, or known fetal developmental anomaly
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xinli Ni, Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>General Hospital of Ningxia Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xinli Ni, Dr.</last_name>
    <phone>86-951-674-3252</phone>
    <email>xinlini6@nyfy.com.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yi Chen, M.D.</last_name>
    <phone>86-951-674-3252</phone>
    <email>czzyxgp@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>General Hospital of Ningxia Medical University</name>
      <address>
        <city>Yinchuan</city>
        <state>Ningxia</state>
        <zip>750004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 11, 2020</study_first_submitted>
  <study_first_submitted_qc>February 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2020</study_first_posted>
  <last_update_submitted>February 13, 2020</last_update_submitted>
  <last_update_submitted_qc>February 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coload</keyword>
  <keyword>Inferior vena cava collapsibility index</keyword>
  <keyword>Norepinephrine</keyword>
  <keyword>Cesarean section</keyword>
  <keyword>Dose-finding</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

